<?xml version="1.0" encoding="UTF-8"?>
<abstract abstract-type="author-highlights" id="abs0015">
 <title>Highlights</title>
 <p>
  <list list-type="simple" id="ulist0010">
   <list-item id="u0010">
    <label>•</label>
    <p id="p0010">In SARS-CoV-2, genetic diversity exists but has limited impact on antigenicity.</p>
   </list-item>
   <list-item id="u0015">
    <label>•</label>
    <p id="p0015">Second and possibly third SARS-CoV-2 waves are expected, only to be controlled with safe and effective vaccines.</p>
   </list-item>
   <list-item id="u0020">
    <label>•</label>
    <p id="p0020">Immunopathology plays a role in severe Covid-19, with a role for macrophages, T lymphocytes and potentially antibodies.</p>
   </list-item>
   <list-item id="u0025">
    <label>•</label>
    <p id="p0025">Normally taking many years, under the outbreak paradigm, the goal is to achieve vaccine development within 12–18 months.</p>
   </list-item>
  </list>
 </p>
</abstract>
